1. Home
  2. CTKB vs IMOS Comparison

CTKB vs IMOS Comparison

Compare CTKB & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • IMOS
  • Stock Information
  • Founded
  • CTKB 1990
  • IMOS 1997
  • Country
  • CTKB United States
  • IMOS Taiwan
  • Employees
  • CTKB N/A
  • IMOS N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • IMOS Semiconductors
  • Sector
  • CTKB Health Care
  • IMOS Technology
  • Exchange
  • CTKB Nasdaq
  • IMOS Nasdaq
  • Market Cap
  • CTKB 708.8M
  • IMOS 813.1M
  • IPO Year
  • CTKB 2021
  • IMOS N/A
  • Fundamental
  • Price
  • CTKB $6.46
  • IMOS $19.40
  • Analyst Decision
  • CTKB Strong Buy
  • IMOS
  • Analyst Count
  • CTKB 3
  • IMOS 0
  • Target Price
  • CTKB $9.17
  • IMOS N/A
  • AVG Volume (30 Days)
  • CTKB 892.8K
  • IMOS 25.5K
  • Earning Date
  • CTKB 11-05-2024
  • IMOS 11-05-2024
  • Dividend Yield
  • CTKB N/A
  • IMOS 5.72%
  • EPS Growth
  • CTKB N/A
  • IMOS 7.03
  • EPS
  • CTKB N/A
  • IMOS 0.07
  • Revenue
  • CTKB $201,210,000.00
  • IMOS $724,842,895.00
  • Revenue This Year
  • CTKB $7.85
  • IMOS $15.65
  • Revenue Next Year
  • CTKB $14.82
  • IMOS $13.49
  • P/E Ratio
  • CTKB N/A
  • IMOS $13.57
  • Revenue Growth
  • CTKB 9.88
  • IMOS 13.31
  • 52 Week Low
  • CTKB $4.66
  • IMOS $19.19
  • 52 Week High
  • CTKB $9.87
  • IMOS $32.19
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 58.79
  • IMOS 29.00
  • Support Level
  • CTKB $5.68
  • IMOS $19.19
  • Resistance Level
  • CTKB $7.26
  • IMOS $19.73
  • Average True Range (ATR)
  • CTKB 0.47
  • IMOS 0.31
  • MACD
  • CTKB -0.03
  • IMOS -0.12
  • Stochastic Oscillator
  • CTKB 53.94
  • IMOS 6.54

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About IMOS ChipMOS TECHNOLOGIES INC.

ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. The Company derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.

Share on Social Networks: